Sprott Inc.

SEC CIK: 0001512920
Latest filing: Jul 28, 2026

SEC filings (opens in a new tab)

LCTX holding history

Lineage Cell Therapeutics, Inc. in every 13F filed by Sprott Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LCTX overview All 13F holders of LCTX Full Q2 2026 holdings

Shares (Q1 2026): 0; Sold out in Q1 2026
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q2 2025

Holdings of LCTX by Sprott Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2026	0	$0	0.0%	−10,000−100.0%	Sold out	Holders
Q4 2025	10,000	$16.7K	<0.1%	00.0%	Unchanged	Holders
Q3 2025	10,000	$16.9K	<0.1%	00.0%	Unchanged	Holders
Q2 2025	10,000	$9.07K	<0.1%	+10,000	New	Holders